2-(Pyridin-4-yl)morpholine, 95.0%, 250mg

2-Chloro-N-(2-methoxy-ethyl)-acetamide, 95.0%, 250mg

4-Methyl-2,6-dioxo-8-(thiophen-2-yl)hexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-ium-8-uide, 95.0%, 5g

3,5-Di-tert-butylaniline, 95.0%, 5g

(4-bromobenzyl)dimethylamine, 95.0%, 5g

(R)-2,2,2-Trifluoro-1-(4-chloro-phenyl)-ethylamine hydrochloride, 97%, 500mg

Oxazolo[5,4-b]pyridin-2-amine, 95.0%, 250mg

2-Phenylamino-propionic acid, 95.0%, 5g

Ethyl 3-amino-5-(3,4-dimethoxyphenyl)thiophene-2-carboxylate, 97%, 250mg

N-(4-((4-Aminophenyl)thio)phenyl)-4-(4-methoxyphenylsulfonamido)butanamide, 98.0%, 100mg

2-(2,6-Dichlorophenyl)sulfanylacetonitrile, 1g

4-(Trifluoromethoxy)benzoic acid hydrazide, 95.0%, 5g

L-γ-Azidohomalanine hydrochloride, min. 98%, 5 mg, plastic packaging.